-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Androgen excess in girls with congenital adrenal hyperplasia (CAH) results in variable degrees of virilization of the external genitalia
Androgen excess in girls with congenital adrenal hyperplasia (CAH) results in variable degrees of virilization of the external genitalia
This is an ethical dilemma because currently unaffected fetuses receive unnecessary treatment during the first trimester of fetal life
And most importantly, there is insufficient evidence for the safety of the fetus undergoing treatment
Third, so far, there is little data on maternal safety
So far, little data on maternal safety
OBJECTIVE: The aim of this study was to reflect current international perceptions of Pdex and practice across Europe at CAH, and to highlight the importance of longitudinal follow-up of treated cases and prospective clinical trials investigating different aspects of the therapy
Methods: A questionnaire with 17 questions was designed and distributed to collect quantitative and qualitative data
RESULTS: Pdex treatment is currently offered in 36 % of surveyed centres
Figure 1
Figure 1
Table 1
Table 1
This study revealed high international variability and variability in the use of Pdex treatment across Europe
Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe
Leave a Comment